Login / Signup

Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.

Martina MagniGiulia BianconSara RizzitanoAlessandra CavanèChiara PaolizziMatteo DugoPaolo CorradiniCristiana Carniti
Published in: British journal of cancer (2019)
Our data provide the rationale for clinical testing of the dasatinib-CHOEP combination in patients with T-cell lymphoma.
Keyphrases
  • tyrosine kinase
  • epidermal growth factor receptor
  • electronic health record
  • locally advanced
  • clinical trial
  • big data
  • machine learning
  • rectal cancer
  • data analysis
  • radiation therapy